Data_Sheet_1_Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation.xlsx
Platelet Derived Growth Factor Receptor Alpha (PDGFRA) mutations occur in only about 5–7% of gastrointestinal stromal tumors (GIST), notably with alterations on exons 12/14/18. The most frequent PDGFRA mutation is the exon 18 D842V, which is correlated to specific clinico-pathological features, such as primary imatinib resistance and higher indolence. Here, we present a gene expression profile (GEP) comparison of D842V vs. PDGFRA with mutations other than D842V (non-D842V). GEP was followed by in silico bioinformatic analysis aimed at evaluating differential expression, tumor microenvironment composition and pathway enrichment. We found a large set of oncogenes, transcription factors and nuclear receptors downregulated in the D842V mutant. Conversely, D842V showed a significant enrichment of immune- and interferon- related gene signatures. Differences in tumor microenvironment composition were also highlighted, including a higher abundance of CD8+ T-cells and an overexpression of the T cell-inflamed signature in the D842V mutant subgroup, which is predictive of immunotherapy response. PDGFRA D842V vs. non-D842V GIST display a different expression profile, with a prominent immunological signature, that could represent a proof of principle for testing immunotherapeutic strategies in this drug-orphan subset of GIST.
History
References
- https://doi.org//10.1126/science.1079666
- https://doi.org//10.1200/JCO.2005.14.068
- https://doi.org//10.1016/S0016-5085(03)01046-1
- https://doi.org//10.1200/JCO.2003.04.190
- https://doi.org//10.1016/j.ejca.2003.11.025
- https://doi.org//10.1158/1078-0432.CCR-11-3025
- https://doi.org//10.4143/crt.2015.015
- https://doi.org//10.1200/JCO.2008.17.4284
- https://doi.org//10.1200/JCO.2007.15.7461
- https://doi.org//10.1158/1078-0432.CCR-12-0625
- https://doi.org//10.1158/1078-0432.CCR-18-1858
- https://doi.org//10.3390/ijms19030732
- https://doi.org//10.1080/2162402X.2019.1617588
- https://doi.org//10.1172/JCI124108
- https://doi.org//10.1172/JCI91190
- https://doi.org//10.1038/nm.2438
- https://doi.org//10.1084/jem.20130875
- https://doi.org//10.1158/1078-0432.CCR-16-1163
- https://doi.org//10.1158/2326-6066.CIR-17-0345
- https://doi.org//10.1038/labinvest.3700122
- https://doi.org//10.1158/1078-0432.CCR-14-1677
- https://doi.org//10.1097/PAS.0000000000000418
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity